Anti-Gout Drugs Market to Witness an Outstanding Growth by 2025
Anti-gout drugs are also known as anti-hyperuricemic drugs. Gout is rare in children. People who have had an organ transplant or kidney disease, or men aged between 40 and 50 are more prone to gout. Anti-gout drugs correct the under excretion or overproduction of uric acid. These can effectively control hyperuricemia for a long term that is caused due to formation of uric acid from purines. The choice of uricosuric medicines or xanthine oxidase inhibitors is based on presence of...
View full press release